Tumor News and Research

RSS

Study examines role of risk factors in development of ER-positive and ER-negative breast cancers

Karla Kerlikowske, MD, and team recently published a paper in the Journal of the National Cancer Institute that examined the role of common risk factors in the development of ER-positive and ER-negative breast cancers.

10 Jan 2017

Scientists gain new insights into molecular mechanisms of breast cancer development

Why does breast cancer develop and how come certain patients are resistant to established therapies? Researchers from the University of Basel have gained new insights into the molecular processes in breast tissue.

9 Jan 2017

UI scientists reveal how high-dose vitamin C damages cancer cells

Vitamin C has a patchy history as a cancer therapy, but researchers at the University of Iowa believe that is because it has often been used in a way that guarantees failure.

9 Jan 2017

Research findings may provide new treatment for prevention of cancer metastasis

Breast cancer metastasis, the process by which cancer spreads, may be prevented through the new use of a class of drugs already approved by the U.S. Food and Drug Administration.

9 Jan 2017

Drug that improves blood flow in damaged heart may be possible treatment option for TNBC

Researchers are looking at a drug once used to improve blood flow in damaged hearts in thousands of patients as a possible treatment option for triple negative breast cancer (TNBC).

6 Jan 2017

Houston Methodist researchers advance potential treatment for metaplastic breast cancer

Houston Methodist Hospital researchers have advanced a potential treatment for metaplastic breast cancer--the most aggressive subtype of triple negative breast cancer, into patients in just under four years.

6 Jan 2017

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Results of an initial study of tumors from patients with lung cancer or head and neck cancer suggest that the widespread acquired resistance to immunotherapy drugs known as checkpoint inhibitors may be due to the elimination of certain genetic mutations needed to enable the immune system to recognize and attack malignant cells.

6 Jan 2017

Researchers develop innovative method to manufacture biocompatible implantable microdevices

A team of researchers led by Biomedical Engineering Professor Columbia Engineering has developed a way to manufacture microscale-sized machines from biomaterials that can safely be implanted in the body.

5 Jan 2017

Study provides new insights into molecular subtypes of esophageal cancer

A comprehensive analysis of 559 esophageal and gastric cancer samples, collected from patients around the world, suggests the two main types of esophageal cancer differ markedly in their molecular characteristics and should be considered separate diseases.

5 Jan 2017

New research suggests novel combination approach to fight against gliomas

"Devastating" and "dismal." That's how leading researchers describe the present outlook for malignant brain tumors. The median survival rate for patients with glioblastoma multiforme, or GBM, is a mere 14.2 months.

4 Jan 2017

Penn State researchers create smart, targeted system to attack specific cancers types

Many groups are working to discover new, safer ways to deliver drugs that fight cancer to the tumor without damaging healthy cells.

4 Jan 2017

MMP9 enzyme could suppress tumors in colitis associated cancer, new study finds

An enzyme that plays an active role in inflammation could be a natural way to suppress tumors and ulcers in the colon that are found in colitis associated cancer (CAC), a type of colorectal cancer that is driven by chronic inflammation, according to a new study.

3 Jan 2017

HER2-targeted dendritic cell vaccine shows promise for treating early-stage breast cancer patients

Deregulation and inhibition of the immune system contributes to cancer development. Many therapeutic strategies aim to restimulate the immune system to recognize cancer cells and target them for destruction.

3 Jan 2017

Researchers reveal how inflammatory responses block fat cell conversion

Scientists at the University of Bonn have shown in mice that excess pounds can simply be melted away by converting unwanted white fat cells into energy-consuming brown slimming cells.

3 Jan 2017

Targeting Legumain could be promising strategy for treatment of cancer

Legumain (LGMN), or asparaginyl endopeptidase, is a newly identified lysosomal cysteine protease.

3 Jan 2017

Nanohyperthermia may prove effective as adjuvant cancer treatment with chemotherapy

The mechanical resistance of tumors and collateral damage of standard treatments often hinder efforts to defeat cancers.

2 Jan 2017

Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Biocept, Inc., a leading commercial provider of clinically actionable liquid biopsy tests designed to improve the outcomes of cancer patients, announces that Columbia University Medical Center will conduct a study to evaluate the clinical utility of the Company's Target Selector™ platform to diagnose leptomeningeal metastases (LM) in patients with breast cancer.

30 Dec 2016

Study suggests new options for improving cancer immunotherapy

One of the main reasons cancer remains difficult to treat is that cancer cells have developed a multitude of mechanisms that allow them to evade destruction by the immune system.

30 Dec 2016

NFCR scientists develop new treatment for brain cancer

The National Foundation for Cancer Research (NFCR) today congratulated Dr. Web Cavenee and Dr. Paul B. Fisher on their discovery of a new pharmacological agent to treat glioblastoma multiforme (GBM), the deadliest brain cancer, which they have been developing together with NFCR support.

30 Dec 2016

A new strategy to fight prostate cancer

A new study led by scientists from the Florida campus of The Scripps Research Institute (TSRI) sheds light on a signaling circuit in cells that drives therapy resistance in prostate cancer.

30 Dec 2016

Tumor News and Research

Study examines role of risk factors in development of ER-positive and ER-negative breast cancers

Scientists gain new insights into molecular mechanisms of breast cancer development

UI scientists reveal how high-dose vitamin C damages cancer cells

Research findings may provide new treatment for prevention of cancer metastasis

Drug that improves blood flow in damaged heart may be possible treatment option for TNBC

Houston Methodist researchers advance potential treatment for metaplastic breast cancer

Cancers acquire resistance to immunotherapy by eliminating tumor-specific genetic mutations

Researchers develop innovative method to manufacture biocompatible implantable microdevices

Study provides new insights into molecular subtypes of esophageal cancer

New research suggests novel combination approach to fight against gliomas

Penn State researchers create smart, targeted system to attack specific cancers types

MMP9 enzyme could suppress tumors in colitis associated cancer, new study finds

HER2-targeted dendritic cell vaccine shows promise for treating early-stage breast cancer patients

Researchers reveal how inflammatory responses block fat cell conversion

Targeting Legumain could be promising strategy for treatment of cancer

Nanohyperthermia may prove effective as adjuvant cancer treatment with chemotherapy

Columbia University Medical Center to evaluate Biocept's Target Selector platform to diagnose LM in breast cancer patients

Study suggests new options for improving cancer immunotherapy

NFCR scientists develop new treatment for brain cancer

A new strategy to fight prostate cancer

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Exploring the G:Box and for high-quality imaging

Latest News